2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Intra-abdominal Infection: new trials by email Literature Review of Intra-abdominal Infection trials Research Report on Intra-abdominal Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections meropenem - Necrotizing Enterocolitis, Intra-abdominal Infection | Phase 1 / Phase 2 | Completed | The Emmes Company, LLC | 200 | 2008-06-01 | 2023-04-25 |
| Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age Tygacil - Bacterial Infections, Intra-Abdominal Infection | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 59 | 2007-12-01 | 2012-10-24 |
Intraabdominal Infections (2) · Bacterial Infections (1) · Enterocolitis, Necrotizing (1) · Pneumonia, Bacterial (1) · Skin Diseases, Bacterial (1) · Skin Diseases, Infectious (1)
Infections (2) · Bacterial Infections and Mycoses (1) · Digestive System Diseases (1) · Enterocolitis (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Lung Diseases (1) · Pneumonia (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Meropenem (1) · Tigecycline (1)
The Emmes Company, LLC (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (2) · Belgium (1) · Mexico (1) · South Africa (1) · Taiwan (1) · Ukraine (1)
Danny Benjamin, MD, PhD, MPH (1)